Federal regulators have approved the first “biosimilar” drug to be sold in the U.S. under a program intended to spur a new market of lower-cost alternatives to some of the most expensive treatments in healthcare.
Modern Healthcare Breaking News
Novartis cancer drug gets FDA's first 'biosimilar' nod
Saturday, March 7, 2015
Novartis cancer drug gets FDA's first 'biosimilar' nod
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment